Concepedia

Publication | Open Access

Identifying the Safety Profile of Ad5.SSTR/TK.RGD, a Novel Infectivity-Enhanced Bicistronic Adenovirus, in Anticipation of a Phase I Clinical Trial in Patients with Recurrent Ovarian Cancer

DOIFull Paper Access

23

Citations

20

References

2009

Year

Kellie S. Matthews, Patricia E. Noker, Baohong Tian, Sheila Grimes, Ronna Fulton, Karen Schweikart, Raymond D. Harris, Rose Aurigemma, Minghui Wang, Mack N. Barnes,
Clinical Cancer Research

Abstract

These studies provide justification for planned dosing of Ad5.SSTR/TK.RGD for a planned phase I clinical trial and insights regarding anticipated toxicity.

References

YearCitations

Page 1